HOME >> BIOLOGY >> NEWS
Fantastic voyage into the heart delivers a protector against heart failure

Reminiscent of the 1966 sci-fi thriller Fantastic Voyage, where a surgical team is miniaturized and injected into a dying man, researchers from Harvard Medical School have used injectable self-assembling peptide nanofibers loaded with the pro-survival factor PDGF-BB to protect rat cardiomyocytes from injury and subsequent heart failure. Their study appears online on December 15 in advance of print publication in the January 2006 issue of the Journal of Clinical Investigation.

Narrowed or blocked blood vessels are unable to deliver sufficient levels of oxygen to cardiomyocytes, which results in cardiomyocyte death, loss of the middle layer of the heart wall (the myocardium), and ultimately, heart failure. Therefore, therapies that protect cardiomyocytes from death may help prevent heart failure. In normal heart tissue, cardiomyocytes are surrounded by an intricate network of capillaries, and interaction of cardiomyocytes with endothelial cells that line the vessel wall and secrete PDGF-BB is integral to cardiomyocyte development and function. In the current study, Richard Lee and colleagues show that PDGF-BB has a direct pro-survival effect on cardiomyocytes. The authors went on to design a strategy in which short, self-assembling peptide nanofibers bind this pro-survival growth factor and, following injection into rat myocardium, facilitated prolonged and controlled delivery of PDGF-BB to the infarcted heart for up to 14 days. This strategy protected cardiomyocytes from injury, reduced infarct size, and preserved cardiac function. This effect could not be achieved by injecting nanofibers or PDGF-BB alone.

These nanofibers represent unique biomaterials able to deliver therapeutic agents directly to the injured tissue and as such hold great potential in the field of tissue regeneration, particularly following cardiac injury.


'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Dec-2005


Page: 1

Related biology news :

1. Fantastic Voyage: A new nanoscale view of the biological world
2. Caribbean frog populations started with single, ancient voyage on South American raft
3. Caribbean frogs started with a single, ancient voyage on a raft from South America
4. Researchers take fantastic voyage through the human body
5. High blood pressure, low energy -- a recipe for heart failure
6. Abnormal fat metabolism underlies heart problems in diabetic patients
7. Cardio exercise benefits in male vs. female hearts
8. Using stem cells to help heart attack victims
9. System to analyze beating heart stem cells could lead to heart attack treatments
10. Cardiac patches stimulate regeneration, improve function after heart attack
11. Specific type of cell death may accelerate decompensated heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) ... severe COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 ...
(Date:8/12/2020)... (PRWEB) , ... August 11, 2020 , ... ... subsidiary based in Princeton, NJ, have entered into license agreements with Housey Pharma’s ... development. Both Roche and J&J have annual Research and Development spending in ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... Texas (PRWEB) , ... August 06, 2020 , ... ... and DNA vaccine industries, announces it has closed on the purchase of greenfield ... Park in Conroe, TX and includes over 21 acres in the initial acquisition, ...
(Date:8/3/2020)... LEXINGTON, Ky. (PRWEB) , ... August 03, 2020 , ... ... innovative products for transformative growth, , Known as MediVet Biologics ... Health brand. , The new Ardent Animal Health will build on its ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader in ... “BUILDING FOR LIFE.” The adoption of this taglines comes at a time of ... capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. ...
(Date:7/31/2020)... SHREWSBURY, Mass. (PRWEB) , ... July 29, 2020 ... ... clad wire that can combine up to three different materials for use with ... can combine up to three materials to meet specific design requirements, performance, and ...
Breaking Biology Technology:
Cached News: